Wednesday 30 October
An innovator’s journey from a napkin sketch to a first-in-human
Dr Intan Oldakowska, Co-Founder and Chief Executive Officer, Earflo
The rise of radiopharmaceuticals – How Australian biotech is at the forefront of this resurgence
Ivan Greguric, Head of Radiochemistry, NST, Health Research and Technology Group
Professor Stephen Rose, SVP Translational Medicine and Clinical Science
Thursday 31 October
Growth of Antibody-Drug Conjugates (ADC’s): The present and future opportunities
Clinical trials in Australia: Performance, competitive advantages, challenges and evolving policy
Funding your life science business: How to navigate the opportunities offered by dilutive and non-dilutive funding
Placing Australia's hat back in the ring for Early Clinical Trials
Deborah Bell, Executive Director Business Development, Avania
Lachlan Porter, Clinical Research Consultant, Clinico
AgriBiotech & Biosecurity Summit
AgriBiotech & Biosecurity, Agriculture Victoria Research
Dr Simone Warner, Head of Agriculture Victoria Research
Animal Biotechnology - opportunities and impacts in the post genome era
Tim Doran, Senior Principal Research Scientist, Health & Biosecurity Research Unit
Innovation Showcase
Esther A. Onyango, Team Leader – Nutrition and Equity, CSIRO
Dr Louise Robertson, Postdoctoral Research Fellow, School of Biomedicine, The University of Adelaide
Peter Mee, Senior Research Scientist - Virology, Agriculture Victoria
Friday 1 November
Behind the headlines: Therapeutics development from academic lab, to spin out and exit
Dr Anne-Laure Puaux, Head of Business Development & CEO, WEHI Ventures
The potential of emerging non-animal models for medical product development
Dr Kim Fung, Principal Research Scientist, CSIRO
Practical & legal considerations of deploying AI in the biotech sector - now and future
David Hansen, Chief Executive Officer & Research Director, Australian e-Health Research, CSIRO
Synergy in science: Integrating AI, robotics and quantum computing for drug discovery
Dr Robert Marino, Chief Executive Officer, Qubit Pharmaceuticals
Cell & Gene Summit
A holistic approach to cell & gene therapies is crucial for the life science industry
Abhi Gupta, Senior Vice President & Head of Cell & Gene Therapy, Syneos Health
Streamlining market access to advanced therapies: What can we learn from global models?
Commercialisation of cell and gene therapies: What does it take
Sam Cobb, Chief Executive Officer, Currus
Dr Cameron Smith, Partner, FB Rice
Ethical access and emerging technologies in cell and gene therapies
Prof Christine Wells, Chair, Stem Cell Systems, The University of Melbourne